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Abstract. Dilated cardiomyopathy (DCM) due to a
primary supraventricular tachycardia not originating
from the sinus node is not frequently seen in older
children or adolescents. However, it is important to
recognize this entity as a reversible cause of DCM to
avoid costly and inappropriate treatments for these
patients. We describe 7 patients who presented with
DCM. Five were misdiagnosed as having ‘‘sinus’’
tachycardia secondary to an idiopathic DCM, and 2
were correctly diagnosed as having DCM secondary
to an atrial tachycardia. All underwent electrophysi-
ologic treatment of the tachycardia with remission of
the DCM.
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Non-sinus supraventricular tachycardia (SVT), de-
fined as a rapid heart rate for age secondary to an
abnormal mechanism originating proximal to the
bifurcation of the bundle of His, is the most common
symptomatic dysrhythmia in childhood and may
present at any age [7, 9–11], including the fetus [19,
20]. A reversible form of DCM can occur with
chronic arrhythmias and is referred to as ‘‘tachycar-
diomyopathy’’ [5]. Cessation of the arrhythmia by
drug therapy [17, 19], radiofrequency ablation (RFA)
of the tachycardia circuit [4, 12–14], or surgical ab-
lation [15] results in the recovery of myocardial
function even if the arrhythmia is of long-standing
duration. Although SVT-induced DCM is a well-
recognized entity in adults with chronic atrial and
ventricular tachycardias [1, 5, 13, 15] as well as in
infants [8, 9, 20], its occurrence in older children and
adolescents is rare [4, 12, 14]. The purpose of this
paper is to describe the clinical course of a group of
older children and adolescents who presented with
DCM secondary to an initially unrecognized non-si-
nus SVT, reminding the pediatric cardiology com-
munity of this reversible cause of DCM.
Materials and Methods
Patient Selection
In a retrospective review, our combined patients from 1985 to the
present who presented to our institutions with tachyarrhythmia
and symptomatic DCM were analyzed. All required the pre-
requisite of absence of previous episodes of tachyarrhythmia and/
or structural congenital heart defects. A total of 7 patients, 6
males and 1 female, ages 7–14 years (median 12 years) were
identified.
Electrophysiology Study/Radiofrequency Ablation
Initial drug therapy consisted of digoxin, furosemide, and spiron-
olactone in all, and amiodarone and sotalol in 2 patients, respec-
tively (patients C and G) (Table 1). However, due to persistent
clinical symptoms and intractable tachycardia following initial di-
agnostic evaluation and medical treatment, all patients were re-
ferred to a cardiac electrophysiologist for more detailed
electrocardiographic analysis. Intracardiac electrophysiologic (EP)
studies with RFA were performed in all after obtaining written
informed consent. Mapping techniques included intracardiac elec-
trograms in 6, and three-dimensional computer reconstruction of
the tachycardia wave dispersion in 1 patient.
Patient Follow-up
After suppressing the SVT with RFA in 5, and with additional
antiarrhythmic therapy in 2, 6 patients were followed at regular
intervals. At the time of this paper, all patients had received follow-
up EGG, exercise stress tests, and serial echocardiograms 3–6
months after initial presentation.Correspondence to: P.P. Karpawich
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Left Ventricular Function Assessment
Left ventricular shortening fraction (LVSF) and end-diastolic di-
mension (LVEDD) were assessed by two-dimensional echocardi-
ography within days prior to and after 3–6 months (median 5
months) following the ablation procedure.
Patient Functional Status
Clinical status was assessed by the New York Heart Association
(NYHA) CHF (congenstive heart failure) classification prior to
and one month after RFA.
Statistics
Results are reported as median values. The paired Student t-test
was used to compare measured indices before and after RFA.
Significance was defined at p < 0.05. The Wilcoxon signed ranks
test was used for ordinal data such as NYHA CHF class, with
significance defined at p < 0.05.
Results
Patient Characteristics
Admission ECG showed narrow QRS tachycardia in
all patients, with a heart rate ranging from 135 to
234/min (median 190/min). Two patients presented
to our institutions with a diagnosis of primary
DCM, 3 presented with a presumed diagnosis of
viral myocarditis causing secondary DCM, and 2
were correctly diagnosed as having primary non-si-
nus SVT with secondary DCM. In 5 patients the
tachycardia was believed by the admitting physicians
to be sinus in origin (Table 1). The definitive diag-
nosis of primary non-sinus SVT with secondary
DCM was made after careful examination of the
surface EGG by the electrophysiologists who iden-
tified variable P wave morphology in all 5 patients,
1 of whom had first degree A-V block (Fig. 1a).
SVT with absent P waves and atrial ectopic tachy-
cardia were diagnosed in 2 patients, respectively.
Based on their clinical presentation, 3 patients were
initially classified as NYHA class II, 2 as NYHA
class III, and 2 as NYHA class IV. LVSF ranged
from 10 to 30% (median 20%) and LVEDD ranged
from 4.75 to 7.98 cm (median 5 cm).
Electrophysiologic Studies and Radiofrequency
Ablation
EP studies revealed atrioventricular reciprocating
tachycardia with septal bypass tract in 1 patient,
atrial ectopic tachycardia in 4, and atrial muscle re-
entry tachycardia in 2, 1 of whom also exhibited
junctional ectopic tachycardia and sinus node dys-
function (Table 1). RFA restored sinus rhythm in all
but 1 patient who had sinus node dysfunction prior to
the RFA procedure (Fig. 1b).
Follow-up of LV Function After RFA
LVSF improved from 10–30% (median 20%) to 31–
38% (median 32%, p = 0.003), and LVEDD de-
creased from 4.75–7.98 cm (median 5.7 cm) to 4.3–6.4
cm (median 5 cm, p = 0.02) after RFA (Fig. 2).
Exercise stress test showed no inducible dysrhythmia
in any patient.
Table 1. Patient characteristics and diagnosis before and after radiofrequency ablation
Patient Age (years) HR (bpm) Diagnosis pre-RFA Diagnosis post-RFA
A 7 200 AET-induced DCM AET focus from the crista of the RA.
B 9 234 Viral myocarditis - Sinus tachycardia Orthodromic AVRT with R septal bypass tract.
C 9 167 Idiopathic DCM - Sinus tachycardia Multiple atrial muscle macro-reentry circuits:
AF from base of RAA (all with distinct cycle
lengths). JET. SN dysfunction (prior to RFA)
D 12 167 Viral myocarditis - Sinus tachycardia AET focus from low antero-septal region of the
RA.
E 13 190 Idiopathic DCM - Sinus tachycardia AET focus from the posterior septum of the
RA.
F 13 135 Viral myocarditis - Sinus tachycardia AET focus from the anterior septum of the RA.
G 14 190 Non-sinus SVT-induced DCM Atrial muscle macro-reentry circuit from para-
SN region.
HR (bpm), heart rate in beats per minute; RFA, radiofrequency ablation; AVRT, atrio-ventricular reciprocating tachycardia; AET, atrial
ectopic tachycardia; AF, atrial flutter; RAA, right atrial appendage; CS, coronary sinus; JET, junctional ectopic tachycardia; SN, sinus
node; RFA, radiofrequency ablation; DCM, dilated cardiomyopathy; SVT, supraventricular tachycardia.
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Fig. 1. (A) Electrocardiogram on admission. A 12-lead EGG from
a 13-year-old boy who presented with CHF. He was misdiagnosed
as having viral myocarditis with ‘‘sinus tachycardia at a rate of 160/
min with first degree atrioventricular block with P waves buried in
the preceding QRS.’’ Even though P waves can be seen on the
preceding T waves in precordial leads V2 and V3 (arrows), they are
not consistently seen in lead II. When present, P wave morphology
is not distinct, therefore the frontal axis is not clear. These three
factors discard the diagnosis of sinus origin of the tachycardia with
first degree atrioventricular block in favor of an ill-defined atrial
rhythm. (B) A 12-lead ECG 3 months later from the same patient
after radiofrequency ablation of the non-sinus tachycardia focus.
Sinus rhythm is now evident. Lead II shows two normally con-
ducted atrial premature beats with one followed by a normally
conducted escape beat (arrows), perhaps from the same focus. P
waves can be clearly seen now preceding the QRS in all leads.
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Resolution of Congestive Heart Failure
In 5 of 7 patients, inotropic and antiarrhythmic
medications were discontinued after RFA. One pa-
tient who was found to have sinus node dysfunction
at the time of the EP study remained in junctional/
low atrial rhythm with occasional episodes of SVT at
a slower rate than on initial presentation (from 190/
min before RFA to 100/min after RFA). The inter-
mittent dysrrhythmia, however, was well tolerated
and did not hinder this patient’s recovery from CHF.
He was receiving digoxin, enalapril, amiodarone, and
aspirin at the time of his latest follow-up. One patient
with atrial ectopic tachycardia required sotalol and
digoxin after RFA failed to completely suppress the
atrial tachycardia. This patient was in sinus rhythm
at the time of follow-up. Prior to correct diagnosis of
non-sinus SVT and effective therapy by RFA and
antiarrhythmic medication, 2 patients were consid-
ered NYHA IV and 2 were considered NYHA III for
heart transplantation. Following treatment, all 7 pa-
tients became asymptomatic within 1–2 months
(NYHA class I).
Discussion
Clinical presentations of non-sinus SVT vary from
hydrops and CHF in the newborn [8, 20] to episodes
of symptomatic tachycardia or CHF and DCM in
children, adolescents [4, 7], and adults [1, 5, 13].
Mechanisms of SVT include reentry and automatic-
ity. In reentrant tachycardia, abnormal electrical
impulses that originate within one area of the atria
reenter previously depolarized atrial tissue, and at
times utilize anatomic para-AV nodal tissue or ac-
cessory pathways, creating a macro-reentry circuit
within the atrium. An automatic or ectopic SVT re-
sults from a rapid and sustained discharge from one
or more localized ectopic foci [6]. In our study, 4
patients presented with an atrial ectopic SVT, and 3
with atrial reentrant tachycardias (2 atrial muscle
macro-reentry and 1 AV reciprocating tachycardia
with an aberrant pathway). One patient presented
multiple atrial muscle macro-reentry circuits in ad-
dition to a junctional ectopic tachycardia. Due to the
unusual nature of this SVT, a viral myocarditis was
suspected, although not confirmed with serologic
testing (patient C) (Table 1). Persistent or incessant
tachyarrhythmias not only produce regional or global
myocardial contractile abnormalities but can also
provoke myocardial damage with fibrosis and adi-
pose infiltration [1–3].
Following suppression of the atrial tachyarrhyth-
mia with antiarrhythmic therapy and/or RFA, car-
diac function normalizes. In pediatric [4, 12, 14, 17]
and adult studies [1, 5, 13, 15] of atrial dysrrhythmias
clinical improvement (assessed by the NYHA CHF
classification) and echocardiographic evidence of re-
covery of LV systolic dysfunction (assessed by the
LVSF) occurred after atrial tachycardia supression.
In this study, medical therapy with digitalis and
Fig. 2. (A) Left ventricular shortening fraction. Among all pa-
tients, the LVSF improved significantly after RFA and/or antiar-
rhythmic medical therapy. Six months after RFA, the left
ventricular shortening fraction improved from a median of 16 to
32% (p = 0.003). (B) Left ventricular end diastolic diameter. Al-
though the LVEDD decreased significantly 6 months after RFA
(p = 0.02), the LV was still considered to be dilated when com-
pared with normal values for height and weight. The median
LVEDD decreased from 5.7 cm to the final median value of
5 cm.
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diuretics was initiated, prior to RFA of the atrial
tachycardia foci/circuits in all patients, including
those initially diagnosed as having viral myocarditis.
However, medical therapy is unsuccessful in more
than 50% of the patients with atrial ectopic tachy-
cardias (which occurred in 4 of the 7 patients).
Drug therapy is also usually ineffective in modify-
ing the macro-reentry circuit and preventing its re-
currence in atrial flutter [16]. In our patient with
orthodromic AV reciprocating tachycardia (who re-
ceived digitalis initially), a more appropriate treat-
ment would have been a beta or a calcium channel
blocker. Therefore, it is most likely that only after
elucidating the exact tachyarrhytmia mechanism
(which was only achieved with the electrophysiologic
study in 6 of the 7 patients) an effective antiarrhyth-
mic drug was chosen. The patient in whom the elec-
trophysiology study uncovered multiple atrial muscle
macro-reentry circuits and a junctional ectopic
tachycardia (patient C) (Table 1), RFA was ineffec-
tive in terminating the tachycardia. However, by
modifying the tachycardia circuits, RFA allowed the
antiarrhythmic medications (digoxin and amioda-
rone) to achieve complete control of the rapid heart
rate. In our study, cardiac function normalized in all
patients who we were able to be followed up (6 of 7).
In spite of significant regression in the LV size
(measured by the LVEDD) 6 months after cessation/
control of the atrial tachycardia, the LVEDD con-
tinued to exceed the upper limits of normal for the
patients’ height and weight in all cases. This occurs
because sustained, chronic tachycardia diminishes the
number of microtubules in the cardiac myocyte,
which contributes to myocardial contractile dys-
function [18]. Due to depletion of high-energy phos-
phates, LV function requires a minimum of 1 month
after cessation of the tachycardia to improve. Re-
covery of ventricular function is typically followed by
a slower recuperation of LV size that peaks after 6–8
months [5]. This delay in LV size normalization after
resolution of the atrial tachycardia has been ex-
plained from animal studies by demonstrating colla-
gen decrease in the extracellular matrix in
tachycardiomyopathy specimens, causing less adhe-
siveness of the basal membrane to the myocytes and
persistent intracellular spacing [18]. Therefore, while
cardiac contractility improves rapidly (shown by
resolution of clinical symptoms of CHF and by early
enhancement in LVSF) after cessation of the tachy-
cardia, correction of LV dilatation (measured by the
LVEDD) is a slower phenomenon, based on ana-
tomical and histologic remodeling of the heart.
Sinus tachycardia, secondary to inflammatory
processes of the myocardium leading to DCM and
CHF, is more common among older children and
adolescents than DCM secondary to tachyarrhyth-
mia. Consequently, these patients can be easily mis-
diagnosed, potentially leading to inappropriate and
costly treatments, including unnecessary listing for
heart transplant. Therefore, the older child or ado-
lescent who presents with DCM and persistent
tachycardia should be thoroughly evaluated for a
primary atrial tachyarrhythmia. As an example, one
of our patients was initially diagnosed as having sinus
tachycardia with first degree A-V block, which would
be very unusual because physiologic sinus tachycar-
dia is often associated with enhanced A-V conduction
(unless A-V conduction abnormalities exist). There-
fore, in the setting of a symptomatic patient with
DCM, the ECG appearance of a sinus tachycardia
with first degree A-V block may indicate that the
atrial tachycardia is non-sinus. Consequently, ECG
analysis of a patient with tachycardia and DCM re-
quires careful evaluation, looking for absence of P
waves, examining P wave morphology when present,
and paying close attention to the duration of the PR
interval. This can lead to a correct diagnosis and will
permit proper initial therapy for this reversible cause
of heart failure.
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